practolol has been researched along with Chronic Disease in 21 studies
Practolol: A beta-1 adrenergic antagonist that has been used in the emergency treatment of CARDIAC ARRYTHMIAS.
practolol : N-(4-Hydroxyphenyl)acetamide in which the hydrogen of the phenolic hydroxy group is substituted by a 3-(isopropylaminoamino)-2-hydroxypropyl group. A selective beta blocker, it has been used in the emergency treatment of cardiac arrhythmias.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ten patients with severe chronic congestive heart failure (CHF) due to ischaemic heart disease treated with digitalis and diuretics were randomly allocated to oral treatment with prenalterol (100-200 mg daily in addition to their basal treatment) or to intensified treatment with diuretics in a cross-over trial." | 9.05 | Prenalterol as long-term therapy for chronic congestive heart failure. A randomized cross-over trial. ( Areskog, M; Dahlström, U; Karlsson, E; Wranne, B, 1984) |
| "Systemic and coronary hemodynamic effects of prenalterol, a beta-1 receptor agonist, were determined in patients with chronic congestive heart failure, initially after intravenous administration (10 patients) and then after oral administration (eight patients)." | 7.67 | Intravenous and oral prenalterol in congestive heart failure. Effects on systemic and coronary hemodynamics and myocardial catecholamine balance. ( Chatterjee, K; Curran, D; Hoyle, MJ; Parmley, WW; Rabbino, M; Swedberg, K; Wahr, DW, 1984) |
| "After a run-in period practolol was given in the dose of 100 mg twice daily to 29 patients with chronic bronchial asthma on the indication hypertension (12) and supraventricular arrhythmia (17)." | 7.65 | Effects of practolol in combination with terbutaline in the treatment of hypertension and arrhythmias in asthmatic patients. ( Eriksson, NE; Formgren, H, 1975) |
| "Betaxolol (Kerlon, 8) was found to exhibit an appropriate preclinical pharmacological and human pharmacokinetic profile (elevated oral bioavailability and prolonged plasma half-life) for the treatment of chronic cardiovascular diseases such as hypertension and angina." | 5.27 | Synthesis of a series of compounds related to betaxolol, a new beta 1-adrenoceptor antagonist with a pharmacological and pharmacokinetic profile optimized for the treatment of chronic cardiovascular diseases. ( Binet, JL; Cavero, IG; Lefèvre-Borg, F; Manoury, PM; Rousseau, J, 1987) |
| "Ten patients with severe chronic congestive heart failure (CHF) due to ischaemic heart disease treated with digitalis and diuretics were randomly allocated to oral treatment with prenalterol (100-200 mg daily in addition to their basal treatment) or to intensified treatment with diuretics in a cross-over trial." | 5.05 | Prenalterol as long-term therapy for chronic congestive heart failure. A randomized cross-over trial. ( Areskog, M; Dahlström, U; Karlsson, E; Wranne, B, 1984) |
| "Systemic and coronary hemodynamic effects of prenalterol, a beta-1 receptor agonist, were determined in patients with chronic congestive heart failure, initially after intravenous administration (10 patients) and then after oral administration (eight patients)." | 3.67 | Intravenous and oral prenalterol in congestive heart failure. Effects on systemic and coronary hemodynamics and myocardial catecholamine balance. ( Chatterjee, K; Curran, D; Hoyle, MJ; Parmley, WW; Rabbino, M; Swedberg, K; Wahr, DW, 1984) |
| "In many patients with chronic atrial fibrillation, it is difficult to prevent an excessive ventricular rate under stress, even with high levels of digoxin in the blood." | 3.65 | Beta-adrenergic blockade as adjunctive oral therapy in patients with chronic atrial fibrillation. ( Kaplinsky, E; Klein, HO; Yahalom, J, 1977) |
| "After a run-in period practolol was given in the dose of 100 mg twice daily to 29 patients with chronic bronchial asthma on the indication hypertension (12) and supraventricular arrhythmia (17)." | 3.65 | Effects of practolol in combination with terbutaline in the treatment of hypertension and arrhythmias in asthmatic patients. ( Eriksson, NE; Formgren, H, 1975) |
| "Betaxolol (Kerlon, 8) was found to exhibit an appropriate preclinical pharmacological and human pharmacokinetic profile (elevated oral bioavailability and prolonged plasma half-life) for the treatment of chronic cardiovascular diseases such as hypertension and angina." | 1.27 | Synthesis of a series of compounds related to betaxolol, a new beta 1-adrenoceptor antagonist with a pharmacological and pharmacokinetic profile optimized for the treatment of chronic cardiovascular diseases. ( Binet, JL; Cavero, IG; Lefèvre-Borg, F; Manoury, PM; Rousseau, J, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manoury, PM | 1 |
| Binet, JL | 1 |
| Rousseau, J | 1 |
| Lefèvre-Borg, F | 1 |
| Cavero, IG | 1 |
| Bijak, A | 1 |
| Czołpiński, T | 1 |
| Dahlström, U | 1 |
| Areskog, M | 1 |
| Wranne, B | 1 |
| Karlsson, E | 1 |
| Wahr, DW | 1 |
| Swedberg, K | 1 |
| Rabbino, M | 1 |
| Hoyle, MJ | 1 |
| Curran, D | 1 |
| Parmley, WW | 1 |
| Chatterjee, K | 1 |
| Kandt, D | 1 |
| Hackenberger, F | 1 |
| Davidson, C | 1 |
| Thadani, U | 1 |
| Singleton, W | 1 |
| Taylor, SH | 1 |
| Harry, JD | 1 |
| Hugues, FC | 1 |
| Julien, D | 1 |
| Marche, J | 1 |
| Bartsch, P | 1 |
| De'Thomatis, M | 1 |
| Falciola, N | 1 |
| Gallesio, R | 1 |
| Schaanning, J | 1 |
| Vilsvik, JS | 1 |
| Rymar, B | 2 |
| Staśkiewicz, J | 2 |
| Kutarski, A | 1 |
| Yahalom, J | 1 |
| Klein, HO | 1 |
| Kaplinsky, E | 1 |
| Formgren, H | 1 |
| Eriksson, NE | 1 |
| Proto, C | 3 |
| Rovetta, A | 2 |
| Ratti, S | 1 |
| Prandini, BD | 1 |
| Adornato, E | 1 |
| De Caridi, A | 1 |
| Sentissi, M | 1 |
| Schrijen, F | 1 |
| Sadoul, P | 1 |
| Quadri, A | 1 |
| Levi, GP | 1 |
| Levi, G | 1 |
| Kimmel, Z | 1 |
| Kachel, S | 1 |
| Rumiński, W | 1 |
2 reviews available for practolol and Chronic Disease
| Article | Year |
|---|---|
[New drugs with positive inotropic action].
Topics: Adrenergic beta-Agonists; Albuterol; Aminopyridines; Amrinone; Cardiotonic Agents; Chronic Disease; | 1982 |
[Medical therapy of chronic coronary insufficiency].
Topics: Amiodarone; Angina Pectoris; Chronic Disease; Coronary Disease; Digitalis Glycosides; Humans; Lidofl | 1978 |
8 trials available for practolol and Chronic Disease
| Article | Year |
|---|---|
Prenalterol as long-term therapy for chronic congestive heart failure. A randomized cross-over trial.
Topics: Adrenergic beta-Agonists; Aged; Carcinogens; Chronic Disease; Clinical Trials as Topic; Electrocardi | 1984 |
[Clinicopharmacological studies on the bronchoconstrictive side effect of the beta-receptor blockader talinolol (Cordanum, 02-115) in patients with asthma or chronic obstructive lung diseases].
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Asthma; Bronchi; Chronic Disease; Clinical | 1975 |
Comparison of antihypertensive activity of beta-blocking drugs during chronic treatment.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Dose- | 1976 |
Evaluation of intrinsic sympathomimetic activity of beta-adrenoceptor blocking drugs in the treatment of patients with angina pectoris.
Topics: Acute Disease; Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Chronic Disease; Clinical T | 1976 |
Beta1-blocker (practolol) and exercise in patients with chronic obstructive lung disease.
Topics: Adult; Aged; Blood Pressure; Carbon Dioxide; Chronic Disease; Clinical Trials as Topic; Depression, | 1976 |
[Behavior of quinidinemia in the double-blind treatment of chronic atrial fibrillation with quinidine and beta-blockaders].
Topics: Atrial Fibrillation; Chronic Disease; Female; Humans; Male; Middle Aged; Practolol; Quinidine | 1975 |
[Treatment of chronic artrial fibrillation with practolol-quinidine].
Topics: Atrial Fibrillation; Chronic Disease; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; | 1973 |
Double-blind evaluation of practolol and quinidine in the treatment of chronic atrial fibrillation.
Topics: Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Chronic Disease; Clinical Trials as Topic; D | 1973 |
11 other studies available for practolol and Chronic Disease
| Article | Year |
|---|---|
Synthesis of a series of compounds related to betaxolol, a new beta 1-adrenoceptor antagonist with a pharmacological and pharmacokinetic profile optimized for the treatment of chronic cardiovascular diseases.
Topics: Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Antihypertensive Agents; Betaxolol; Biotra | 1987 |
Intravenous and oral prenalterol in congestive heart failure. Effects on systemic and coronary hemodynamics and myocardial catecholamine balance.
Topics: Administration, Oral; Adult; Aged; Catecholamines; Chronic Disease; Coronary Circulation; Female; He | 1984 |
[Effects of beta blockaders on ventilatory function in chronic bronchitis].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Bronchitis; Chronic Disease; Coronary Dise | 1979 |
Chronic obstructive lung disease after practolol.
Topics: Adult; Chronic Disease; Conjunctivitis; Dyspnea; Female; Humans; Lung Diseases, Obstructive; Practol | 1977 |
[Reversal of chronic atrial fibrillation with quinidine and practolol].
Topics: Adult; Aged; Atrial Fibrillation; Chronic Disease; Drug Therapy, Combination; Female; Humans; Male; | 1977 |
Beta-adrenergic blockade as adjunctive oral therapy in patients with chronic atrial fibrillation.
Topics: Administration, Oral; Adult; Aged; Atrial Fibrillation; Chronic Disease; Digoxin; Drug Evaluation; F | 1977 |
Effects of practolol in combination with terbutaline in the treatment of hypertension and arrhythmias in asthmatic patients.
Topics: Adult; Aged; Arrhythmias, Cardiac; Asthma; Blood Pressure; Chronic Disease; Drug Therapy, Combinatio | 1975 |
[Practolol in cardiac arrhythmias].
Topics: Acute Disease; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Compl | 1974 |
[Hemodynamic effects of practolol in chronic bronchopneumopathies].
Topics: Adult; Asthma; Bronchitis; Cardiac Volume; Chronic Disease; Drug Evaluation; Heart Rate; Hemodynamic | 1974 |
[Practolol in the treatment of cardiac arrhythmia resulting from the treatment of bronchospastic disorders with sympathicomimetic drugs].
Topics: Acute Disease; Adult; Aged; Arrhythmias, Cardiac; Bronchial Spasm; Chronic Disease; Drug Evaluation; | 1973 |
[Eraldin in the treatment of arrhythmia].
Topics: Acute Disease; Adolescent; Adult; Aged; Arrhythmias, Cardiac; Chronic Disease; Drug Evaluation; Fema | 1974 |